Celldex Therapeutics shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Celldex Therapeutics by Connor, Clark & Lunn Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $342k | 8.2k | 41.97 |
| 2023-12-31 | $1.1M | 29k | 39.66 |
| 2023-09-30 | $500k | 18k | 27.52 |
| 2023-03-31 | $1.5M | 43k | 35.98 |
| 2022-12-31 | $2.6M | 58k | 44.57 |
| 2022-09-30 | $2.3M | 81k | 28.11 |
| 2021-09-30 | $654k | 12k | 53.97 |
| 2021-06-30 | $486k | 15k | 33.44 |
| 2020-12-31 | $654k | 37k | 17.51 |
| 2020-09-30 | $765k | 52k | 14.83 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management